C Reactive Protein for Risk Stratification in Acute Coronary Syndromes? Verdict: Unproven

Heart
doi 10.1136/heart.89.11.1288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Multimarker Approach to Risk Stratification in Non-St Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Value of Serial Troponin T Measures for Early and Late Risk Stratification in Patients With Acute Coronary Syndromes

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Acute Coronary Syndromes

British Medical Journal
Medicine
2015English

Acute Coronary Syndromes

2018English

Serum Amylase and C-Reactive Protein in Risk Stratification of Pancreas-Specific Complications After Pancreaticoduodenectomy

British Journal of Surgery
Surgery
2016English

Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2008English

Acute Coronary Syndromes

2007English

Acute Coronary Syndromes

2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy